Autoimmune Fibrotic Adverse Reactions in One-Year Treatment with Cabergoline for Women with Prolactinoma

E-ISSN： 2212-3873|16|1|47-55

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.16, Iss.1, 2016-03, pp. : 47-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cabergoline: SUNCT syndrome in a patient with prolactinoma: case report

Reactions Weekly, Vol. 1, Iss. 1136, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

One-Year Treatment with Cholecystokinin-Octapeptide and Secretin: Effects on Pancreatic Trophism in the Rat

By Nagy I.N. Taka Cs T.S. Moha Csi G.B.

Pharmacological Research, Vol. 36, Iss. 1, 1997-07 ,pp. : 77-85

Academic Press

Access to resources Recommend Favorite

Cabergoline: Pituitary apoplexy and acquired resistance in prolactinoma: case report

Reactions Weekly, Vol. 1, Iss. 1331, 2010-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite

Behavioural self-management with problem drinkers: One-year follow-up of a controlled drinking group treatment approach

By Koerkel Joachim

Addiction Research and Theory, Vol. 14, Iss. 1, 2006-02 ,pp. : 35-49

Informa Healthcare

Access to resources Recommend Favorite

Use of Acarbose or Bedtime Insulin after Failure of Treatment with Conventional Oral Antidiabetics: A One-Year Randomised Clinical Trial

By Ko G.T.C.

Clinical Drug Investigation, Vol. 21, Iss. 6, 2001-06 ,pp. : 401-408

Adis International

Access to resources Recommend Favorite